We lost weight on GLP-1 drugs — and then lost our sex drives
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
Senate Leaders Warn Hegseth About Procuring Generic Drugs Overseas — ProPublica
Senate leaders are urging the Department of Defense to prioritize the purchase of generic drugs manufactured in the…
New GLP-1 pill helps patients lose up to 8% of body weight, trial shows | Weight-loss drugs
A new daily pill could be a more effective GLP-1 tablet for weight loss, according to a clinical…
Acid reflux sufferers urged to avoid major ‘error’ when taking medication
People who are battling uncomfortable acid reflux symptoms with medication have been urged to be cautious about one…
Medication shortage hits UK as statins and aspirin ‘disappear from shelves’
A pharmacist has warned people the UK has been hit with a medication shortage. Even popular medicines like…
Anyone taking tablets issued warning over making ‘dangerous’ mistake
People who take medication are being urged to avoid making a major error which could have harmful consequences…
GLP-1 Medications for Weight Loss: How to Get Started | News
Any licensed health care provider—including primary care physicians, nurse practitioners, physician assistants, and specialists such as endocrinologists, cardiologists,…
How Taking a GLP-1 After 50 Is Different, According to Experts
GLP-1s have become a ubiquitous tool for weight loss, but they don’t exactly come with a training manual.…
Breakthrough method gives ‘snapshot’ of a plant’s metabolic effects
Scientists developed a new way to help understand what happens in the body when people consume a plant…
Fake Mounjaro pens supplied through UK online pharmacy
C+D has been informing, supporting and championing community pharmacy since 1859 and is proud to be at the…
Has Australia’s social media ban worked? The eSafety Commissioner is monitoring kids’ Ritalin use to find out
February 26, 2026 — 12:01am Save You have reached your maximum number of saved items. Remove items from…
1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash
Although pegged as a weight-loss stock, this drug maker’s core business has long been diabetes. Novo Nordisk (NVO…